Clinical Trials · NCT05577728
Prediction of the SEPRA Diabetes Trial in Healthcare Claims Data
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Brigham and Women's Hospital
- Enrollment
- 2,316
- Start date
- Jul 2021
- Locations
- 1 site, United States
- Primary endpoint
- Long-term glycemic control defined as proportion of patients who will achieve an HbA1c of less than 7.0% (53.0 mmol/mol)